Find out more about Hal Braley's experience
Hal Braley's highlights
Displaying the 2 most recent scholarly works by Hal Braley.
CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common beta chain of the IL-3, GM-CSF and IL-5 receptors
Con Panousis, Urmi Dhagat, Kirsten M Edwards, Veronika Rayzman, Matthew P Hardy, Hal Braley, Gail M Gauvreau, Timothy R Hercus, Steven Smith, Roma Sehmi, Laura McMillan, Mara Dottore, Barbara J McClure, Louis J Fabri, Gino Vairo, Angel F Lopez, Michael W Parker, Andrew D Nash, Nicholas J Wilson, Michael J Wilson, et al.
Journal article | 2016 | MABS